PYXS
Pyxis Oncology, Inc. Common Stock
$2.02
-9.82%
-0.22
Notify me if price changes either direction
Buy PYXS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
241.3M
Enterprise value
171.7M
Trailing PE
-1.5718750655651
Forward PE
-1.7911295
PEG Ratio
-0.047156251966953
Enterprise to EBITDA
-2.007
Enterprise to revenue
15.553
Price to book MRQ
11.222221
Price to sales TTM
21.86094
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
11.0M
EBITDA
-85526000
Diluted EPS TTM
-1.4
Total Cash (MRQ)
33.0M
Current ratio (MRQ)
1.337
Operating Cash Flow (TTM)
-67910000
PYXS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
